Out-of-specification results were found for atomoxetine content in seven batches and non-compliance in the mass uniformity parameter in batch 1311190, posing a real and direct risk to patients' health or life. Potential effects: reduced treatment efficacy, unstable drug effect, possible worsening of disease symptoms.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the medicine from the listed batches, check the batch number on the packaging and return the product to a pharmacy; if in doubt about the medicine taken or in case of deterioration of healt...
Distribution of the specified batches of Konaten was suspended throughout the country and the decision was given immediate enforceability; the manufacturer halted production of atomoxetine-containing ...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related